{"id":"NCT01025336","sponsor":"Pfizer","briefTitle":"Study Evaluating Persistence Of Antibody Response Elicited By 13vPnC In Healthy Adults Previously Vaccinated","officialTitle":"A Study To Evaluate The Persistence Of The Antibody Response Elicited By 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) In Healthy Adults Who Have Previously Been Vaccinated With Either 2 Doses Of 13vPnC Or 13vPnC And 23-Valent Pneumococcal Polysaccharide Vaccine In Different Sequential Order In Study 6115A1-3010 Or 6115A1 3005","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2009-12","primaryCompletion":"2010-10","completion":"2010-10","firstPosted":"2009-12-03","resultsPosted":"2012-06-20","lastUpdate":"2012-06-20"},"enrollment":962,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"PREVENTION"},"conditions":["Healthy"],"interventions":[{"type":"OTHER","name":"Blood draw","otherNames":[]},{"type":"OTHER","name":"Blood draw","otherNames":[]}],"arms":[{"label":"23vPS Naive","type":"OTHER"},{"label":"Prior 23vPS>/= 5 years","type":"OTHER"}],"summary":"The purpose of this study is to evaluate the levels of antibodies 1 year after receiving the second vaccine dose in two groups of adults over the age of 60: (1) those who have previously received 2 doses of 13-valent pneumococcal conjugate vaccine (13vPnC) and (2) those who have previously received 1 dose of 13vPnc and 1 dose of 23-valent pneumococcal polysaccharide vaccine (23vPS). This study will also assess whether the use of the 2 vaccines, 13vPnC and 23vPS, administered in different sequential order results in different prolonged antibody levels. This study is limited to individuals who participated in either study 6115A1-3010 (NCT00574548) or 6115A1-3005 (NCT00546572).","primaryOutcome":{"measure":"Serotype-Specific Pneumococcal Opsonophagocytic Activity (OPA) Geometric Mean Titer (GMT) Antibody Persistence 1 Year After Vaccination (Vax) 2 in Parent Study 6115A1-3010 (NCT00574548)","timeFrame":"Month 1/Year 2 (Baseline) (Follow-up Study 6115A1-3018; NCT01025336)","effectByArm":[{"arm":"13vPnC/13vPnC Group (23vPs Naïve)","deltaMin":54,"sd":null},{"arm":"13vPnC/23vPS Group (23vPS Naïve)","deltaMin":52,"sd":null},{"arm":"23vPS/13vPnC Group (23vPS Naïve)","deltaMin":36,"sd":null}],"pValues":[]},"eligibility":{"minAge":"60 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":1,"exclusionCount":1},"locations":{"siteCount":29,"countries":["United States"]},"refs":{"pmids":["30648932"],"seeAlso":["https://trialinfoemail.pfizer.com/pages/landing.aspx?StudyID=6115A1-3018&StudyName=Study%20Evaluating%20Persistence%20Of%20Antibody%20Response%20Elicited%20By%2013vPnC%20In%20Healthy%20Adults%20%20Previously%20Vaccinated"]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":130},"commonTop":[]}}